Glasdegib
Back to searchMolecule Structure
Scientific Name
Glasdegib
Description of the Drug
Glasdegib is a sonic hedgehog receptor inhibitor used to treat newly diagnosed acute myeloid leukemia in patients over 75 years who cannot receive intense chemotherapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11978
http://www.drugbank.ca/drugs/DB11978
Brand Name(s)
Not Available
Company Owner(s)
Pfizer Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Smoothened homolog | SINGLE PROTEIN | ANTAGONIST | CHEMBL5971 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2068480 | ||
| DrugBank | DB11978 | ||
| PubChem: Thomson Pharma | 57272690 | ||
| PubChem | 25166913 | ||
| LINCS | LSM-45612 | ||
| Nikkaji | J3.242.404J | ||
| BindingDB | 50385635 | ||
| DrugCentral | 5304 | ||
| ChemicalBook | CB82658197 | ||
| Guide to Pharmacology | 8201 | ||
| rxnorm | GLASDEGIB | DAURISMO | GLASDEGIB MALEATE |
| ChEBI | 145428 | ||
| ZINC | ZINC000068251434 |
